NCT04836923

Brief Summary

Frailty is a significant problem in patients undergoing liver transplant and is associated with poor outcomes and survival. Hence, optimizing physical fitness and counteracting frailty is important. However, many interventions are very resource intensive and therefore not feasible. In this study, the investigators aim to test the effectiveness of a newly designed intervention to improve frailty in liver transplant candidates. The "LIver FrailTy" intervention (LIFT) will consist of an evaluation by a physical therapist, an individualized home exercise prescription (HEP), exercise tracking using a smart phone application, daily text reminders to exercise and recurrent telephone check-ins. The investigators also aim to perform "Realistic Effort Action Planning" (REAP), which is a form of personality-informed motivational interviewing, in a subset of patients to determine if this enhances the LIFT intervention.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2020

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 5, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 8, 2021

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

February 13, 2023

Status Verified

February 1, 2023

Enrollment Period

4.8 years

First QC Date

April 5, 2021

Last Update Submit

February 10, 2023

Conditions

Outcome Measures

Primary Outcomes (6)

  • Frailty

    Frailty is described as a biologic syndrome of decreased physiologic reserve and increased vulnerability to health stressors. This outcome is measured by the Liver frailty index \[LFI\]. LFI is composed of 3 performance-based tests (grip strength, chair stands, and balance). There is no data to date describing the expected range of values. Higher LFI scores indicate a higher degree of frailty.

    Every month for up to 5 years

  • Placement on liver transplant waitlist

    A clinical measure for the participant and where they are located on the liver transplant waiting list.

    Every month for up to 5 years

  • Clinical Outcomes - waitlist / post-transplant mortality

    Measured if a patient dies while listed on the transplant waitlist or post-transplant.

    Every month for up to 5 years

  • Clinical Outcomes - post transplant disposition

    Determined by location of patient after transplant (can be listed such as acute rehabilitation, subacute rehabilitation center, home, etc.)

    Every month for up to 5 years

  • Clinical Outcomes - number and duration of hospitalizations

    Clinical measure for how many times a patient is hospitalized and how long those hospitalizations last.

    Every month for up to 5 years

  • Clinical Outcomes - liver related complications

    Data collected from medical chart for liver related complications including but not limited to diagnosis of: ascites, hepatic encephalopathy, variceal bleeding, hepatorenal syndrome, hepatopulmonary syndrome, infection.

    Every month for up to 5 years

Secondary Outcomes (5)

  • Endurance

    Every 3 months for up to 5 years

  • Patient adherence

    Every week for up to 5 years

  • Degree of hepatic encephalopathy

    Every 3 months for up to 5 years

  • Patient-reported quality of life

    Every 3 months for up to 5 years

  • Personality assessment

    Every month for up to 5 years

Study Arms (2)

LIFT subgroup

EXPERIMENTAL

PT evaluation, an individualized home exercise prescription (HEP), daily text message reminders to exercise and weekly telephone check-ins with team members.

Behavioral: "LIver FrailTy" intervention (LIFT)

LIFT + REAP subgroup

EXPERIMENTAL

PT evaluation, an individualized home exercise prescription (HEP), daily text message reminders to exercise and weekly telephone check-ins with team members. We will also employ "Realistic Effort Action Planning" (REAP), a form of personality-informed motivational interviewing in a subset of patients to potentially enhance patient engagement and adherence to the home-exercise prescription.

Behavioral: "LIver FrailTy" intervention (LIFT)Behavioral: "Realistic Effort Action Planning" intervention (REAP)

Interventions

Novel physical therapy intervention to decrease frailty in pre-transplant patients

LIFT + REAP subgroupLIFT subgroup

This intervention is an interactive behavioral interviewing process to engage patients in their care

LIFT + REAP subgroup

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a diagnosis of liver cirrhosis being evaluated for liver transplantation in hepatology/transplant evaluation clinic
  • English-speaking
  • Patients with access to a smart phone (with videoconference capabilities)
  • Vulnerable populations: We will include patients who are cognitively impaired due to hepatic encephalopathy and unable to consent for themselves.

You may not qualify if:

  • Patients \< 18 years of age
  • Patients who require outpatient physical therapy.
  • Patients without the ability to consent for themselves or through a medical power of attorney.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern Medicine

Chicago, Illinois, 60611, United States

RECRUITING

Related Publications (1)

  • Thuluvath AJ, Polineni P, Morrissey S, Belfanti K, Nizamuddin M, Siddiqui O, Daud A, Simpson DC, Levitsky J, Flores AM, Duarte-Rojo A, Ladner DP. Home-based LIver FrailTy Intervention (LIFT) in Transplant Candidates: A Feasibility Study. Transplantation. 2025 Apr 1;109(4):e202-e212. doi: 10.1097/TP.0000000000005263. Epub 2024 Nov 6.

MeSH Terms

Conditions

FrailtyFibrosis

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Daniela Ladner, MD

    Northwestern University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Surgery - Organ Transplantation

Study Record Dates

First Submitted

April 5, 2021

First Posted

April 8, 2021

Study Start

October 1, 2020

Primary Completion

July 31, 2025

Study Completion

September 1, 2025

Last Updated

February 13, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations